Private Label Bifida Ferment Lysate Serum Manufacturer Low MOQ

Do private label bifida ferment lysate serums need FDA approval?

By Blake Mereby · Last reviewed October 12, 2026

Cosmetic serums sold in the United States, including bifida ferment lysate serums, do not require pre-market approval from the FDA. Cosmetics are regulated under the Federal Food, Drug, and Cosmetic Act (FD&C Act) as amended by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), which took effect for most provisions in 2024. There is no FDA approval pathway for cosmetics equivalent to drug approval—you do not submit your formula for sign-off before selling.

However, MoCRA introduced several new substantive requirements that brands and their contract manufacturers must now comply with. First, cosmetic facility registration: any facility that manufactures or processes cosmetics for US distribution must register with the FDA. If your contract manufacturer is a US facility, confirm they are registered. If they are a foreign facility (e.g., a Korean OEM), the registration obligation still applies to them for US-market goods, and many Korean contract manufacturers are now MoCRA-registered. Second, cosmetic product listing: each product sold in the US must be listed with the FDA, which requires submitting the product name, responsible party, and full INCI ingredient list through the FDA's Cosmetics Direct portal. This is the brand owner's responsibility, not the manufacturer's. Third, serious adverse event reporting: brands must report serious adverse events to the FDA within 15 business days.

On the labeling side, FDA regulations under 21 CFR Part 701 require that all cosmetics display the responsible person's name and address, net weight, ingredient list in descending order of predominance (using INCI names), and any required warnings. Bifida ferment lysate has no specific FDA warning requirement, but if your serum contains certain other actives (e.g., retinol, alpha hydroxy acids above certain concentrations) the regulatory picture becomes more complex.

If your serum makes drug-like claims—'heals the skin barrier,' 'treats eczema,' 'reduces rosacea'—the FDA may classify it as a drug, requiring an entirely different regulatory pathway. Stick to structure-function cosmetic claims: 'helps visibly strengthen the skin's moisture barrier,' 'skin looks calmer and more resilient.'

For EU sales, the regulatory regime is more demanding: EU Cosmetics Regulation 1223/2009 requires a Responsible Person established in the EU, a completed Product Information File (PIF), a Cosmetic Product Safety Report (CPSR) signed by a qualified toxicologist, and notification via the CPNP portal before placing the product on the market. Canada requires notification to Health Canada under the Cosmetic Notification Form (CNF) system within 10 days of first sale.

AJ Cosmo Labs connects founders with manufacturers and regulatory consultants who can guide you through MoCRA compliance and international filings specific to your target markets.

Ingredients in this answer: Retinol

Read the full guide on Private Label Bifida Ferment Lysate Serum Manufacturer Low MOQ →

More about Private Label Bifida Ferment Lysate Serum Manufacturer Low MOQ

Tell us about your product

Tell us what you're selling and where. You can hire a vetted cosmetic chemist on AJ Cosmo Labs to review your formula and labeling. Starting is free.

Free to start · no credit card · continue in your browser or the iPhone app.

Have a product idea?

Connect with vetted cosmetic chemists and custom labs on AJ Cosmo Labs.

Get on the App Store Open the web app